SCYB.V - Scythian Biosciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development1,038.021,038.021,038.02
Selling General and Administrative1,740.4212,868.4061,121.06
Non Recurring---
Total Operating Expenses2,996.2593,040.9061,121.06
Operating Income or Loss-2,996.259-3,040.906-1,121.06
Income from Continuing Operations
Total Other Income/Expenses Net20.195-17.629-62.123
Earnings Before Interest and Taxes-2,996.259-3,040.906-1,121.06
Interest Expense-49.278-49.278-49.278
Income Before Tax-2,976.064-3,058.535-1,183.182
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-2,976.064-3,058.535-1,183.182
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,976.064-3,058.535-1,183.182
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,976.064-3,058.535-1,183.182